Home / News / India News / Article /
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
Updated On: 20 July, 2021 12:00 AM IST | New Delhi | ANI
Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said India has been offered 7.5 million doses of Moderna vaccine through WHO's Covid-19 Vaccines Global Access (COVAX) program

Photo used for representational purpose. Pic/AFP
Officials of the World Health Organisation (WHO) had a meeting with the Hyderabad-based vaccine maker Bharat Biotech and its dossier for Emergency Use Listing (EUL) of Covaxin is under review by technical experts for consideration, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said on Monday.
Dr Singh said that India has been offered 7.5 million doses of Moderna vaccine through WHO's Covid-19 Vaccines Global Access (COVAX) program.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

